Why is Themis Medicare falling/rising?

As of 09-Jul, Themis Medicare Ltd's stock price is currently at 125.05, reflecting a decrease of 4.9 points or 3.77%. The stock has underperformed its sector today by 3.97%, following a trend reversal after two consecutive days of gains. It reached an intraday low of Rs 124.5, and trading volume was concentrated near this low price, indicating a lack of strong buying interest. Over the past week, the stock has declined by 0.44%, and its performance over the past month shows a significant drop of 14.32%. The stock has also experienced a substantial year-to-date decline of 52.48%, alongside a 48.11% decrease over the past year, which is compounded by negative financial results, including a 31.5% fall in profits and a recent PAT of Rs -9.66 crore, marking a drastic decline compared to previous quarters.
In the broader market context, Themis Medicare's recent performance contrasts sharply with the Sensex, which has seen a slight increase of 0.15% over the past week and a 6.91% rise year-to-date. This underperformance is indicative of broader investor sentiment, as domestic mutual funds hold no stake in the company, suggesting a lack of confidence in its future prospects. The company's low debt-to-EBITDA ratio and fair valuation metrics do not seem to offset concerns regarding its poor long-term growth, evidenced by a 7.40% annual growth rate in operating profit over the last five years and a significant drop in net sales. Overall, the combination of negative financial results, poor market sentiment, and underperformance relative to benchmarks contributes to the stock's decline.